Your request has been received by DRG. A represantative will contact you shortly to provide more details on the research and data contained in this report and ensure that it will meet your current research needs.
The European drug delivery device market will see modest growth through 2027. Although the increasing availability of biosimilars will negatively impact ASPs, the greater affordability of lower-cost generic drug delivery devices will support rising overall sales volumes, which will be further supported by expanding patient populations.
This Medtech 360 Report provides high-level market metrics for Drug Delivery Devices in Europe, including country-level data for major countries and aggregate data for the rest of Europe, across a 10-year period.
Already a Client? Log in to access this report.
Sanketh Kamath is an analyst within the Endoscopy and Aesthetics Medtech Insights team at Decision Resources Group, specializing in urology, gynecology, capital equipment, transcatheter embolization and occlusion devices, and medical device outsourcing; he has also worked on standardizing US Procedure Finder codes. Sanketh holds an MBA in Pharmaceutical Marketing from the National Institute of Pharmaceutical Education and Research, India.